| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| Domain | NUT | 8.16e-05 | 5 | 54 | 2 | IPR024310 | |
| Domain | NUT_N | 8.16e-05 | 5 | 54 | 2 | IPR024309 | |
| Domain | NUT | 8.16e-05 | 5 | 54 | 2 | PF12881 | |
| Domain | IGv | 1.33e-03 | 75 | 54 | 3 | SM00406 | |
| Domain | PH | 4.31e-03 | 229 | 54 | 4 | PF00169 | |
| Domain | PH | 8.48e-03 | 278 | 54 | 4 | SM00233 | |
| Domain | PH_DOMAIN | 8.58e-03 | 279 | 54 | 4 | PS50003 | |
| Domain | PH_domain | 8.69e-03 | 280 | 54 | 4 | IPR001849 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | 4.64e-07 | 588 | 57 | 9 | 38580884 | |
| Pubmed | Gab1 and Mapk Signaling Are Essential in the Hair Cycle and Hair Follicle Stem Cell Quiescence. | 1.58e-05 | 4 | 57 | 2 | 26456821 | |
| Pubmed | 1.60e-05 | 689 | 57 | 8 | 36543142 | ||
| Pubmed | 2.43e-05 | 209 | 57 | 5 | 36779422 | ||
| Pubmed | 3.38e-05 | 38 | 57 | 3 | 23273568 | ||
| Pubmed | TGF-β3-expressing CD4+CD25(-)LAG3+ regulatory T cells control humoral immune responses. | 5.51e-05 | 7 | 57 | 2 | 25695838 | |
| Pubmed | 6.31e-05 | 130 | 57 | 4 | 12421765 | ||
| Pubmed | Coupling of Gab1 to c-Met, Grb2, and Shp2 mediates biological responses. | 9.43e-05 | 9 | 57 | 2 | 10871282 | |
| Pubmed | Common variants near TARDBP and EGR2 are associated with susceptibility to Ewing sarcoma. | 9.43e-05 | 9 | 57 | 2 | 22327514 | |
| Pubmed | EGR1 and EGR2 involvement in vertebrate tendon differentiation. | 2.03e-04 | 13 | 57 | 2 | 21173153 | |
| Pubmed | 4.26e-04 | 214 | 57 | 4 | 22199357 | ||
| Pubmed | 4.43e-04 | 19 | 57 | 2 | 15799026 | ||
| Pubmed | 4.73e-04 | 92 | 57 | 3 | 20301317 | ||
| Pubmed | 6.57e-04 | 103 | 57 | 3 | 21706016 | ||
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | 6.97e-04 | 430 | 57 | 5 | 35044719 | |
| Pubmed | 7.12e-04 | 24 | 57 | 2 | 25344368 | ||
| Pubmed | Large-scale cDNA transfection screening for genes related to cancer development and progression. | 8.82e-04 | 114 | 57 | 3 | 15498874 | |
| Pubmed | Mutations in Hcfc1 and Ronin result in an inborn error of cobalamin metabolism and ribosomopathy. | 1.04e-03 | 29 | 57 | 2 | 35013307 | |
| Pubmed | Profiling of tyrosine phosphorylation pathways in human cells using mass spectrometry. | 1.11e-03 | 30 | 57 | 2 | 12522270 | |
| Pubmed | Characterization of long cDNA clones from human adult spleen. | 1.35e-03 | 33 | 57 | 2 | 11214971 | |
| Pubmed | Proteotyping of knockout mouse strains reveals sex- and strain-specific signatures in blood plasma. | 1.43e-03 | 34 | 57 | 2 | 34050187 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr9q22 | 1.15e-04 | 200 | 57 | 4 | chr9q22 | |
| Cytoband | 9q22.32 | 5.21e-04 | 27 | 57 | 2 | 9q22.32 | |
| Cytoband | 15q15.1 | 1.58e-03 | 47 | 57 | 2 | 15q15.1 | |
| ToppCell | severe_COVID-19-NK_CD56bright|World / disease group, cell group and cell class (v2) | 4.30e-05 | 152 | 57 | 4 | ab5a4e47b23d16018642d4c9c7f41b30205edf73 | |
| ToppCell | LPS-IL1RA+antiTNF-Myeloid-Dendritic_cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.41e-05 | 153 | 57 | 4 | c81a88d3f707487c511020d3960a1c41e706c6a0 | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L6_CT|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.76e-05 | 156 | 57 | 4 | fe383ce3a0c37f7343d7026cb51260a04d4c2829 | |
| ToppCell | severe_COVID-19-NK_CD56bright|severe_COVID-19 / disease group, cell group and cell class (v2) | 5.00e-05 | 158 | 57 | 4 | c2e8d96fc29aa2388b92b4fd81d2726e1f7a053f | |
| ToppCell | droplet-Marrow-BM-30m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.78e-05 | 164 | 57 | 4 | b77995958c938e10a526118f75d78cee72e0b207 | |
| ToppCell | normal_Lung-Fibroblasts-Myofibroblasts|Fibroblasts / Location, Cell class and cell subclass | 5.78e-05 | 164 | 57 | 4 | 9b4a6007abae992db871d9f6f731d5af724de30d | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-myeloid_dendritic_cell-proliferating_dendritic|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.96e-05 | 172 | 57 | 4 | b043d4f81dced7fb3326043f68474123be47cc5d | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6_IT-L6_IT_VISp_Penk_Fst|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 7.60e-05 | 176 | 57 | 4 | a1b9f8f199a028b3fa85de43fe96bc29f387bfd8 | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.60e-05 | 176 | 57 | 4 | 76fdf211bce101e83a27d822cb399487bd107027 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_VIP_PRSS8|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.22e-05 | 185 | 57 | 4 | 4c42bd3cd72f91f4d4ebb849069a03761a2cd662 | |
| ToppCell | BAL-Control-Myeloid-MoAM-MoAM5|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.61e-05 | 187 | 57 | 4 | 59d28f4ee1d463ae20abb8d7e7399b504d80698a | |
| ToppCell | Control-Myeloid-MoAM5|Control / Disease group,lineage and cell class （2021.01.30） | 9.61e-05 | 187 | 57 | 4 | 8769341be67382cea2a590d962f4def7c39de883 | |
| ToppCell | BAL-Control-Myeloid-MoAM-MoAM5-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.61e-05 | 187 | 57 | 4 | 25adf648c05c21534b4913254e73d43fc5f64e06 | |
| ToppCell | BAL-Control-Myeloid-MoAM-MoAM5|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 9.61e-05 | 187 | 57 | 4 | 3b0cfa9e5ea5e7d6dda689c328b9b5110b43ee1d | |
| ToppCell | BAL-Control-Myeloid-MoAM-MoAM5-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 9.61e-05 | 187 | 57 | 4 | 0d589de12108230ced5b60229564f4a181e2f172 | |
| ToppCell | IPF-Myeloid-DC_Mature|Myeloid / Disease state, Lineage and Cell class | 1.00e-04 | 189 | 57 | 4 | 49e67d298d045f29136919b7d9971b6502b0efaa | |
| ToppCell | wk_20-22-Mesenchymal-Myofibro_&_SMC-Myofibro_2|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.09e-04 | 193 | 57 | 4 | 2f203f6f0c2135acb046c9351a633c3b5b254a46 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.11e-04 | 194 | 57 | 4 | 91205b22650e7ecdb72bb59348ce2530b76c532c | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.11e-04 | 194 | 57 | 4 | 6e12a7da35be4c0ecf998ef94b8989b89d74b200 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.11e-04 | 194 | 57 | 4 | c52f10140c66e8c0566421c3d535d5d92bf595e1 | |
| ToppCell | facs-Pancreas-Endocrine-18m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.13e-04 | 195 | 57 | 4 | bd8e24dd598990204998d1dd853ba7a53dc0107e | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD8-Tnaive/CM_CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 1.15e-04 | 196 | 57 | 4 | e7fd508cb9a8a5b3d1c0247dabf486c4434b5e94 | |
| ToppCell | MatrixFB-Fibroblast-B_(Myofibroblast)|MatrixFB / shred on cell class and cell subclass (v4) | 1.15e-04 | 196 | 57 | 4 | 38ea0eaf42f95c321ca23570d0d7752980cf00f8 | |
| ToppCell | (5)_Fibroblasts-(5)_Fibroblast-B_(Myofibroblast)|(5)_Fibroblasts / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.20e-04 | 198 | 57 | 4 | 196257c4420ac801ed9fbb444f11718adb7560ae | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW16-Neuronal|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 1.24e-04 | 200 | 57 | 4 | 84e4565d28a02700bf7f6730d1b3a58744ca0aea | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-PAX6-TSPAN12-L1-2|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.24e-04 | 200 | 57 | 4 | 523d799eb315b33b77e02d5b7db63dad8450c4e1 | |
| ToppCell | proximal-mesenchymal-Fibromyocyte-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.24e-04 | 200 | 57 | 4 | 37d9f46f727a31e8e94e348e4ddd71a2125ba01a | |
| ToppCell | proximal-3-mesenchymal-Fibromyocyte|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.24e-04 | 200 | 57 | 4 | ed6fbe61a04d29b105054f7058abe7469314b304 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-PAX6-TSPAN12|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.24e-04 | 200 | 57 | 4 | e5cef95e563a6e793ade190ce88c999bfa0af460 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW16-Neuronal-Cortical_neuron|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 1.24e-04 | 200 | 57 | 4 | 19055194a5e0ea122f1b8fc62df44813f6843c95 | |
| ToppCell | proximal-mesenchymal-Fibromyocyte|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.24e-04 | 200 | 57 | 4 | 49658e1b530de0dad16d45a1112bdf5329bb800d | |
| Drug | bazedoxifene | 6.50e-06 | 51 | 54 | 4 | ctd:C447119 | |
| Disease | Autistic Disorder | 1.25e-03 | 261 | 53 | 4 | C0004352 | |
| Disease | keratinocyte carcinoma | 1.26e-03 | 118 | 53 | 3 | EFO_0010176 | |
| Disease | eosinophil percentage of leukocytes | 2.14e-03 | 746 | 53 | 6 | EFO_0007991 | |
| Disease | respiratory system disease | 2.27e-03 | 145 | 53 | 3 | EFO_0000684 | |
| Disease | Eczema | 2.33e-03 | 310 | 53 | 4 | HP_0000964 | |
| Disease | ejection fraction measurement | 2.73e-03 | 43 | 53 | 2 | EFO_0005527 | |
| Disease | Multiple Sclerosis | 2.98e-03 | 45 | 53 | 2 | C0026769 | |
| Disease | Multiple Sclerosis, Acute Fulminating | 2.98e-03 | 45 | 53 | 2 | C0751324 | |
| Disease | Agents acting on the renin-angiotensin system use measurement | 3.08e-03 | 335 | 53 | 4 | EFO_0009931 | |
| Disease | Diuretic use measurement | 3.50e-03 | 169 | 53 | 3 | EFO_0009928 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PVPIKVCPRSPPLET | 501 | Q9BYV9 | |
| LRPDACGPVKEPPEI | 41 | Q9P2K8 | |
| KSPRDRCSPPPPPRE | 396 | P46098 | |
| RKPFPCPLDTLRVPP | 246 | P11161 | |
| DPPCRAATPQKPEPK | 746 | O60890 | |
| PETRVSCLPPEPPKT | 191 | Q5HY64 | |
| EPLCPAVPPRKAVPV | 71 | Q9BRK4 | |
| LRQVRPPSCPVPFPE | 41 | O95751 | |
| PKTPPRRPVPVADCE | 501 | Q13480 | |
| RRPVPVADCEPPPVD | 506 | Q13480 | |
| PPPATRERPPGCKTV | 116 | Q16206 | |
| FRPPPALCARPVKEP | 26 | Q9UHG2 | |
| REKTPEPPVPCVPEQ | 231 | Q15116 | |
| KQRPVVCSVPPRLPP | 4136 | Q9NYQ8 | |
| CEAPPPVVATPRPKG | 1106 | Q14999 | |
| VPDLPPRKPHDCVPT | 171 | Q9Y4U1 | |
| VPPTSPGPPERERDC | 91 | P23677 | |
| CISKETPAPVVPPEP | 5101 | Q5VST9 | |
| RVISRPPPSVSPPKC | 1021 | Q8NHM5 | |
| PEPNCPAPRKVEVPG | 151 | P48745 | |
| PPPTIPPARDVCKGA | 2306 | Q99715 | |
| FRKADGREPCPVVPP | 1911 | Q8TD84 | |
| PECRPPESPGPREKT | 41 | Q7Z6J4 | |
| KARTPCRLPPPAPEP | 91 | Q9Y2Y9 | |
| PPTPRSPKAQRPVAC | 256 | Q8N8Q3 | |
| CPVTRAPPPPEPKAE | 21 | O14556 | |
| PPPAPRPSREQKCVK | 16 | Q2VPK5 | |
| TACLPPPRPQRPVTK | 391 | Q5VT03 | |
| ACLPPPRPQRPAETK | 341 | A1L443 | |
| ACLPPPRPQRPAETK | 341 | Q5VZR2 | |
| DEPPAPPAVCPRKRC | 206 | Q5VY09 | |
| LRCPPPPVRRSEKPN | 51 | Q9H9J2 | |
| ECSPPLTVEPPVRPL | 1676 | Q5JRA6 | |
| RAPPPPRPCLRKEVF | 371 | Q9BWN1 | |
| DSPPPKPPRTRSCLV | 331 | Q05209 | |
| CPLSRLFEEPEKPPP | 926 | O15357 | |
| PAIVPPKKFRQCPEP | 1266 | Q7Z333 | |
| PSPRIIPPSPTCAEK | 746 | Q14940 | |
| RIPPPAPRPSVECTG | 21 | Q6ZUB1 | |
| CPVPKPRVDRPRKVP | 226 | Q9NXX6 | |
| PARPEVLCRKEPAPP | 871 | Q5T8A7 | |
| KEVPRNDTCPELPPP | 636 | Q6UXD5 | |
| PTPPVRVMACEPPAL | 1476 | A1L4H1 | |
| PIVIRDSPVPCTPPA | 461 | Q6ZRI6 | |
| PDRCEAPPVPPRRER | 11 | Q7L0Q8 | |
| PPRVIQHCPPPKSRS | 841 | Q01973 | |
| RLPPAPVSGEPPERC | 146 | A6NEH8 | |
| DTVPPPPPSKVGKRC | 1371 | Q7Z2Z1 | |
| EPAPEDPPKQRCRAP | 751 | P21580 | |
| LPEPAPRPPDGTRCV | 936 | Q7Z410 | |
| RDERPPPAKLPCLSP | 271 | Q8N9G6 | |
| RDERPPPAKLPCLSP | 271 | A8MUA0 | |
| GRPPKVPVREVCPVT | 281 | Q15906 | |
| SLCPVPPPPERKSCE | 581 | Q9C0I4 | |
| PPPPERKSCEIPCRM | 586 | Q9C0I4 | |
| PPPPVIFCHDSPKRV | 16 | Q7RTV3 | |
| DAPVRCRPEPLGPPE | 376 | Q53EQ6 | |
| PRPCPGPKRPVSLEL | 391 | Q53SZ7 | |
| DPVPIPDKRRKPAPA | 191 | Q9H7L9 | |
| PHARPELPERPPCKV | 241 | Q6ZRP0 | |
| RPVPSLPDVCPKEPT | 31 | Q9P1Q0 |